{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:06:49Z","timestamp":1784293609077,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.mehy.2015.08.025","type":"journal-article","created":{"date-parts":[[2015,9,5]],"date-time":"2015-09-05T12:05:24Z","timestamp":1441454724000},"page":"969-971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Topical sulfonylurea as a novel therapy for hypertrichosis secondary to diazoxide, and potentially for other conditions with excess hair growth"],"prefix":"10.1016","volume":"85","author":[{"given":"Ron S.","family":"Newfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2015.08.025_b0005","first-page":"882","article-title":"Use of diazoxide with trichlormethiazide for hypertension","volume":"112","author":"Okun","year":"1963","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.mehy.2015.08.025_b0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1749-6632.1968.tb19062.x","article-title":"Hypertrichosis lanuginosa associated with diazoxide therapy in prepubertal children: a clinicopathologic study","volume":"150","author":"Koblenzer","year":"1968","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.mehy.2015.08.025_b0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4274\/Jcrpe.821","article-title":"Hyperinsulinaemic hypoglycaemia:genetic mechanisms, diagnosis and management","volume":"4","author":"Mohamed","year":"2012","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"Suppl. 1","key":"10.1016\/j.mehy.2015.08.025_b0020","first-page":"163","article-title":"Medications used in the treatment of hypoglycemia due to congenital hyperinsulinism of infancy (HI)","volume":"2","author":"Hussain","year":"2004","journal-title":"Pediatr Endocrinol Rev"},{"issue":"2","key":"10.1016\/j.mehy.2015.08.025_b0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.6065\/apem.2014.19.2.57","article-title":"Congenital hyperinsulinism: current status and future perspectives","volume":"19","author":"Yorifuji","year":"2014","journal-title":"Ann Pediatr Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mehy.2015.08.025_b0030","doi-asserted-by":"crossref","first-page":"E355","DOI":"10.1210\/jc.2012-2169","article-title":"Genotype and phenotype correlations in 417 children with congenital hyperinsulinism","volume":"98","author":"Snider","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 3","key":"10.1016\/j.mehy.2015.08.025_b0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2337\/diacare.13.3.18","article-title":"Sulfonylureas. Why, which, and how?","volume":"13","author":"Melander","year":"1990","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.mehy.2015.08.025_b0040","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMoa055068","article-title":"Activating mutations in the ABCC8 gene in neonatal diabetes mellitus","volume":"355","author":"Babenko","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.mehy.2015.08.025_b0045","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/dc07-1785","article-title":"Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations","volume":"31","author":"Rafiq","year":"2008","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.mehy.2015.08.025_b0050","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1096\/fj.07-099424","article-title":"Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil","volume":"22","author":"Shorter","year":"2008","journal-title":"FASEB J"},{"issue":"5","key":"10.1016\/j.mehy.2015.08.025_b0055","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00424-006-0116-z","article-title":"ABCC8 and ABCC9: ABC transporters that regulate K+ channels","volume":"453","author":"Bryan","year":"2007","journal-title":"Pflugers Arch"},{"issue":"3","key":"10.1016\/j.mehy.2015.08.025_b0060","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1152\/physrev.00027.2009","article-title":"Muscle KATP channels: recent insights to energy sensing and myoprotection","volume":"90","author":"Flagg","year":"2010","journal-title":"Physiol Rev"},{"issue":"4","key":"10.1016\/j.mehy.2015.08.025_b0065","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.0022-202X.2005.23643.x","article-title":"Novel and established potassium channel openers stimulate hair growth in vitro: implications for their modes of action in hair follicles","volume":"124","author":"Davies","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"7","key":"10.1016\/j.mehy.2015.08.025_b0070","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ng.2324","article-title":"Dominant missense mutations in ABCC9 cause Cant\u00fa syndrome","volume":"44","author":"Harakalova","year":"2012","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.mehy.2015.08.025_b0075","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.ajhg.2012.04.014","article-title":"Cant\u00fa syndrome is caused by mutations in ABCC9","volume":"90","author":"van Bon","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.mehy.2015.08.025_b0080","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejmg.2013.09.009","article-title":"Mutation of KCNJ8 in a patient with Cant\u00fa syndrome with unique vascular abnormalities \u2013 support for the role of K(ATP) channels in this condition","volume":"56","author":"Brownstein","year":"2013","journal-title":"Eur J Med Genet"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987715003321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987715003321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:16:01Z","timestamp":1759691761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987715003321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0306987715003321"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2015.08.025","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical sulfonylurea as a novel therapy for hypertrichosis secondary to diazoxide, and potentially for other conditions with excess hair growth","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2015.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}